Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis

J Thornton, DM Ashcroft, MZ Mughal… - Archives of disease in …, 2006 - adc.bmj.com
Aims: To evaluate the currently available evidence for the effectiveness of bisphosphonates
in children with low bone mineral density (BMD) and fragility fractures associated with …

[HTML][HTML] A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk …

J Thornton, D Ashcroft, T O'neill, R Elliott… - Health Technology …, 2008 - europepmc.org
Objectives To review outcome measures and treatment costs in children with juvenile
idiopathic arthritis (JIA) and low bone mineral density (BMD) and/or fragility fractures. To …

Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study

ML Bianchi, R Cimaz, M Bardare… - … : Official Journal of …, 2000 - Wiley Online Library
Objective Osteopenia/osteoporosis is being increasingly reported as a complication of many
chronic diseases, even in children. In this preliminary study, we evaluated the effect of an …

Efficacy and safety of bisphosphonate therapy in children with osteogenesis imperfecta: a systematic review

EBG Rijks, BC Bongers, MJG Vlemmix… - Hormone research in …, 2015 - karger.com
Abstract Background/Aims: To systematically assess contemporary knowledge regarding the
effectiveness and safety of bisphosphonates (BPs) in children with osteogenesis imperfecta …

Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large …

S Stagi, L Masi, S Capannini, R Cimaz… - The Journal of …, 2010 - jrheum.org
Objective. To assess the prevalence of reduced spine bone mineral apparent density
(BMAD), and to identify the main predictors of reduced spine BMAD in a cross-sectional and …

Use of bisphosphonates in the treatment of pediatric osteoporosis

LM Ward, A Petryk, CM Gordon - International Journal of …, 2009 - search.proquest.com
Bisphosphonates are increasingly prescribed for children with primary and secondary
osteoporosis. Despite this, many questions remain as to the optimal agent, and the dose and …

Causes, mechanisms and management of paediatric osteoporosis

O Mäkitie - Nature reviews rheumatology, 2013 - nature.com
Osteoporosis, a skeletal disorder characterized by compromised bone strength and an
increased risk of fractures, is an important paediatric disorder that involves almost all …

Osteoporosis in childhood

F Vierucci, G Saggese, R Cimaz - Current opinion in …, 2017 - journals.lww.com
Osteoporosis in childhood : Current Opinion in Rheumatology Osteoporosis in childhood :
Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe Get new …

Osteoporosis in children and adolescents: how to treat and monitor?

S Ciancia, W Högler, RJB Sakkers… - European Journal of …, 2023 - Springer
Osteoporosis is a condition of increased bone fragility associated with fractures. Apart from
primary genetic osteoporotic conditions, secondary osteoporosis in children is being …

Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review

H Castillo, L SAMSON‐FANG… - … Medicine & Child …, 2009 - Wiley Online Library
This systematic review of the effects of bisphosphonate treatment in children with
osteogenesis imperfecta was conducted using the American Academy for Cerebral Palsy …